Lovesac Co (LOVE) stock
Close on Oct 30, 2026Market cap $235.54MP/E 13.5Yield –
Earnings
Lovesac's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Lovesac's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Nov 2, 2026 | Dec 10, 2026Expected | – | – | – | – | – |
| Q2 FY2027ended Aug 2, 2026 | Sep 10, 2026before the open | $161.20M | +0.4% | $0.51 | – | Release |
| Q1 FY2027ended May 3, 2026 | Jun 11, 2026before the open | $138.20M | -0.1% | -$0.76 | -$10.50 | Release |
| Q4 FY2026ended Feb 1, 2026 | Mar 26, 2026before the open | $248.00M | +2.7% | $2.19 | – | Release |
| Q3 FY2026ended Nov 2, 2025 | Dec 11, 2025before the open | $150.20M | +0.2% | -$0.72 | – | Release |
| Q2 FY2026ended Aug 3, 2025 | Sep 11, 2025before the open | $160.50M | +2.5% | -$0.45 | – | Release |
| Q1 FY2026ended May 4, 2025 | Jun 12, 2025before the open | $138.40M | +4.4% | -$0.73 | – | Release |
| Q4 FY2025ended Feb 2, 2025 | Apr 10, 2025before the open | $241.50M | -3.6% | $2.13 | – | Release |
| Q3 FY2025ended Nov 3, 2024 | Dec 12, 2024before the open | $149.90M | -2.7% | -$0.32 | – | Release |
| Q2 FY2025ended Aug 4, 2024 | Sep 12, 2024before the open | $156.60M | +1.4% | -$0.38 | – | Release |
| Q1 FY2025ended May 5, 2024 | Jun 13, 2024before the open | $132.60M | -6.1% | -$0.83 | – | Release |
| Q4 FY2024ended Feb 4, 2024 | Apr 11, 2024before the open | $250.50M | +4.9% | $1.87 | – | Release |
| Q3 FY2024ended Oct 29, 2023 | Dec 6, 2023before the open | $154.00M | +14.2% | -$0.15 | – | Release |
| Q2 FY2024ended Jul 30, 2023 | Nov 3, 2023before the open | $154.50M | +4.0% | -$0.04 | – | Release |
| Q1 FY2024ended Apr 30, 2023 | Jun 7, 2023before the open | $141.20M | +9.1% | -$0.28 | – | Release |
| Q4 FY2023ended Jan 29, 2023 | Mar 28, 2023before the open | $238.80M | +21.7% | $1.74 | – | Release |
| Q3 FY2023ended Oct 30, 2022 | Dec 7, 2022before the open | $134.80M | +15.5% | -$0.55 | – | Release |
| Q2 FY2023ended Jul 31, 2022 | Sep 8, 2022before the open | $148.50M | – | $0.45 | – | Release |
| Q1 FY2023ended May 1, 2022 | Jun 8, 2022before the open | $129.40M | – | $0.12 | – | Release |
| Q4 FY2022ended Jan 30, 2022 | Mar 29, 2022before the open | $196.20M | – | $2.03 | – | Release |
| Q3 FY2022ended Oct 31, 2021 | Dec 8, 2021before the open | $116.70M | – | $0.17 | – | Release |
| Q2 FY2022ended Aug 1, 2021 | Sep 9, 2021before the open | – | – | – | – | Filing |
| Q1 FY2022ended May 2, 2021 | Jun 9, 2021before the open | – | – | – | – | Filing |
| Q4 FY2021ended Jan 31, 2021 | Apr 14, 2021before the open | – | – | – | – | Filing |
| Q3 FY2021ended Nov 1, 2020 | Dec 10, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2021ended Aug 2, 2020 | Sep 9, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Lovesac's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | Q3 FY2027 | $140.00M – $150.00M | – | New | Sep 10, 2026 |
| Adjusted EBITDA lossnon-GAAP | Q3 FY2027 | $7.00M – $10.00M | – | New | Sep 10, 2026 |
| Basic loss per common shareGAAP | Q3 FY2027 | $0.62 – $0.83 | – | New | Sep 10, 2026 |
| Net lossGAAP | Q3 FY2027 | $9.00M – $12.00M | – | New | Sep 10, 2026 |
| Net sales | FY2027 | $690.00M – $710.00M | $700.00M – $740.00M | Lowered | Sep 10, 2026 |
| Adjusted EBITDAnon-GAAP | FY2027 | $31.50M – $35.50M | $35.00M – $46.00M | Lowered | Sep 10, 2026 |
| Diluted income per common shareGAAP | FY2027 | $0.98 – $1.26 | $0.34 – $0.81 | Raised | Sep 10, 2026 |
| Net incomeGAAP | FY2027 | $14.50M – $18.50M | $5.00M – $12.00M | Raised | Sep 10, 2026 |
Guidance vs results
The last range Lovesac gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2027 | EPS (GAAP) | $0.20 – $0.48 | $0.51 | Above range |
| Q2 FY2027 | Revenue | $157.00M – $166.00M | $161.20M | Within range |
| Q1 FY2027 | EPS (GAAP) | $0.95 – $1.22 | -$0.76 | Below range |
| Q1 FY2027 | Revenue | $133.00M – $139.00M | $138.20M | Within range |
| FY2026 | EPS (GAAP) | $0.15 – $0.49 | $0.29Σ4Q | Within range |
| FY2026 | Revenue | $685.00M – $705.00M | $697.10MΣ4Q | Within range |
| Q4 FY2026 | EPS (GAAP) | $1.88 – $2.22 | $2.19 | Within range |
| Q4 FY2026 | Revenue | $236.00M – $256.00M | $248.00M | Within range |
| Q3 FY2026 | Revenue | $151.00M – $161.00M | $150.20M | Below range |
| Q2 FY2026 | EPS (GAAP) | $0.58 – $0.83 | -$0.45 | Below range |
| Q2 FY2026 | Revenue | $157.00M – $166.00M | $160.50M | Within range |
| Q1 FY2026 | Revenue | $136.00M – $142.00M | $138.40M | Within range |
| FY2025 | EPS (GAAP) | $0.27 – $0.74 | $0.60Σ4Q | Within range |
| FY2025 | Revenue | $660.00M – $680.00M | $680.60MΣ4Q | Above range |
| Q4 FY2025 | EPS (GAAP) | $1.67 – $2.14 | $2.13 | Within range |
| Q4 FY2025 | Revenue | $221.00M – $241.00M | $241.50M | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.28 – $0.50 | -$0.32 | Below range |
| Q3 FY2025 | Revenue | $152.00M – $160.00M | $149.90M | Below range |
| Q2 FY2025 | EPS (GAAP) | $0.37 – $0.53 | -$0.38 | Below range |
| Q2 FY2025 | Revenue | $152.00M – $160.00M | $156.60M | Within range |
| Q1 FY2025 | EPS (GAAP) | $0.84 – $1.03 | -$0.83 | Below range |
| Q1 FY2025 | Revenue | $126.00M – $132.00M | $132.60M | Above range |
| Q4 FY2024 | EPS (GAAP) | $1.77 – $2.02 | $1.87 | Within range |
| Q4 FY2024 | Revenue | $260.00M – $270.00M | $250.50M | Below range |
| Q3 FY2024 | EPS (GAAP) | -$0.33 – -$0.20 | -$0.15 | Above range |
| Q3 FY2024 | Revenue | $154.00M | $154.00M | Within range |
| Q2 FY2024 | EPS (GAAP) | $0.12 – $0.16 | -$0.04 | Below range |
| Q2 FY2024 | Revenue | $149.00M – $151.00M | $154.50M | Above range |
| Q1 FY2024 | EPS (GAAP) | $0.36 – $0.37 | -$0.28 | Below range |
| Q1 FY2024 | Revenue | $133.00M – $136.00M | $141.20M | Above range |
Guidance history
Every forecast Lovesac put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 10, 2026 | Adjusted EBITDA | FY2027 | $31.50M – $35.50M | Lowered |
| Sep 10, 2026 | Adjusted EBITDA loss | Q3 FY2027 | $7.00M – $10.00M | New |
| Sep 10, 2026 | Diluted income per common share | FY2027 | $0.98 – $1.26 | Raised |
| Sep 10, 2026 | Net income | FY2027 | $14.50M – $18.50M | Raised |
| Sep 10, 2026 | Net loss | Q3 FY2027 | $9.00M – $12.00M | New |
| Sep 10, 2026 | Basic loss per common share | Q3 FY2027 | $0.62 – $0.83 | New |
| Sep 10, 2026 | Net sales | FY2027 | $690.00M – $710.00M | Lowered |
| Sep 10, 2026 | Net sales | Q3 FY2027 | $140.00M – $150.00M | New |
| Jun 11, 2026 | Adjusted EBITDA | FY2027 | $35.00M – $46.00M | Raised |
| Jun 11, 2026 | Adjusted EBITDA | Q2 FY2027 | -$4.00M – $2.00M | New |
| Jun 11, 2026 | Diluted income per common share | FY2027 | $0.34 – $0.81 | Lowered |
| Jun 11, 2026 | Basic loss per common share | Q2 FY2027 | $0.20 – $0.48 | New |
| Jun 11, 2026 | Net income | FY2027 | $5.00M – $12.00M | Lowered |
| Jun 11, 2026 | Net loss | Q2 FY2027 | $3.00M – $7.00M | New |
| Jun 11, 2026 | Net sales | FY2027 | $700.00M – $740.00M | Lowered |
| Jun 11, 2026 | Net sales | Q2 FY2027 | $157.00M – $166.00M | New |
| Mar 26, 2026 | Adjusted EBITDA | FY2027 | $33.00M – $44.00M | New |
| Mar 26, 2026 | Adjusted EBITDA loss | Q1 FY2027 | $12.00M – $16.00M | New |
| Mar 26, 2026 | Diluted income per common share | FY2027 | $0.34 – $0.95 | New |
| Mar 26, 2026 | Basic loss per common share | Q1 FY2027 | $0.95 – $1.22 | New |
| Mar 26, 2026 | Net income | FY2027 | $5.00M – $14.00M | New |
| Mar 26, 2026 | Net loss | Q1 FY2027 | $14.00M – $18.00M | New |
| Mar 26, 2026 | Net sales | FY2027 | $700.00M – $750.00M | New |
| Mar 26, 2026 | Net sales | Q1 FY2027 | $133.00M – $139.00M | New |
| Dec 11, 2025 | Adjusted EBITDA | FY2026 | $37.00M – $43.00M | Lowered |
| Dec 11, 2025 | Adjusted EBITDA | Q4 FY2026 | $51.00M – $56.00M | New |
| Dec 11, 2025 | Diluted income per common share | FY2026 | $0.15 – $0.49 | Lowered |
| Dec 11, 2025 | Diluted income per common share | Q4 FY2026 | $1.88 – $2.22 | New |
| Dec 11, 2025 | Net income | FY2026 | $2.00M – $8.00M | Lowered |
| Dec 11, 2025 | Net income | Q4 FY2026 | $30.00M – $36.00M | New |
| Dec 11, 2025 | Net sales | FY2026 | $685.00M – $705.00M | Lowered |
| Dec 11, 2025 | Net sales | Q4 FY2026 | $236.00M – $256.00M | New |
| Sep 11, 2025 | Adjusted EBITDA | FY2026 | $42.00M – $55.00M | Lowered |
| Sep 11, 2025 | Adjusted EBITDA loss | Q3 FY2026 | -$7.00M – -$1.00M | New |
| Sep 11, 2025 | Diluted income per common share | FY2026 | $0.52 – $1.05 | Lowered |
| Sep 11, 2025 | Net income | FY2026 | $8.00M – $17.00M | Lowered |
| Sep 11, 2025 | Net loss | Q3 FY2026 | -$12.00M – -$8.00M | New |
| Sep 11, 2025 | Basic loss per common share | Q3 FY2026 | -$0.83 – -$0.51 | New |
| Sep 11, 2025 | Net sales | FY2026 | $710.00M – $740.00M | Narrowed |
| Sep 11, 2025 | Net sales | Q3 FY2026 | $151.00M – $161.00M | New |
| Jun 12, 2025 | Adjusted EBITDA | FY2026 | $48.00M – $60.00M | Reaffirmed |
| Jun 12, 2025 | Adjusted EBITDA loss | Q2 FY2026 | $2.00M – $7.00M | New |
| Jun 12, 2025 | Diluted income per common share | FY2026 | $0.80 – $1.36 | Reaffirmed |
| Jun 12, 2025 | Basic loss per common share | Q2 FY2026 | $0.58 – $0.83 | New |
| Jun 12, 2025 | Net income | FY2026 | $13.00M – $22.00M | Reaffirmed |
| Jun 12, 2025 | Net loss | Q2 FY2026 | $8.00M – $12.00M | New |
| Jun 12, 2025 | Net sales | FY2026 | $700.00M – $750.00M | Reaffirmed |
| Jun 12, 2025 | Net sales | Q2 FY2026 | $157.00M – $166.00M | New |
| Apr 10, 2025 | Adjusted EBITDA | FY2026 | $48.00M – $60.00M | New |
| Apr 10, 2025 | Adjusted EBITDA loss | Q1 FY2026 | -$12.00M – -$8.00M | New |
| Apr 10, 2025 | Diluted income per common share | FY2026 | $0.80 – $1.36 | New |
| Apr 10, 2025 | Net income | FY2026 | $13.00M – $22.00M | New |
| Apr 10, 2025 | Net loss | Q1 FY2026 | -$13.00M – -$10.00M | New |
| Apr 10, 2025 | Basic loss per common share | Q1 FY2026 | -$0.85 – -$0.66 | New |
| Apr 10, 2025 | Net sales | FY2026 | $700.00M – $750.00M | New |
| Apr 10, 2025 | Net sales | Q1 FY2026 | $136.00M – $142.00M | New |
| Dec 12, 2024 | Adjusted EBITDA | FY2025 | $37.50M – $48.50M | New |
| Dec 12, 2024 | Adjusted EBITDA | Q4 FY2025 | $43.00M – $55.00M | New |
| Dec 12, 2024 | Diluted income per common share | FY2025 | $0.27 – $0.74 | New |
| Dec 12, 2024 | Diluted income per common share | Q4 FY2025 | $1.67 – $2.14 | New |
| Dec 12, 2024 | Net income | FY2025 | $4.50M – $12.50M | New |
| Dec 12, 2024 | Net income | Q4 FY2025 | $28.00M – $36.00M | New |
| Dec 12, 2024 | Net sales | FY2025 | $660.00M – $680.00M | New |
| Dec 12, 2024 | Net sales | Q4 FY2025 | $221.00M – $241.00M | New |
| Sep 12, 2024 | Adjusted EBITDA | Q3 FY2025 | -$3.00M – $1.00M | New |
| Sep 12, 2024 | Adjusted EBITDA | FY2025 | $52.00M – $59.00M | Narrowed |
| Sep 12, 2024 | Basic loss per common share | Q3 FY2025 | $0.28 – $0.50 | New |
| Sep 12, 2024 | Diluted income per common share | FY2025 | $1.01 – $1.26 | Lowered |
| Sep 12, 2024 | Net loss | Q3 FY2025 | $4.00M – $8.00M | New |
| Sep 12, 2024 | Net income | FY2025 | $17.00M – $21.00M | Lowered |
| Sep 12, 2024 | Net sales | Q3 FY2025 | $152.00M – $160.00M | New |
| Sep 12, 2024 | Net sales | FY2025 | $700.00M – $735.00M | Lowered |
| Jun 13, 2024 | Adjusted EBITDA loss | Q2 FY2025 | $2.00M – $5.00M | New |
| Jun 13, 2024 | Adjusted EBITDA | FY2025 | $46.00M – $60.00M | Reaffirmed |
| Jun 13, 2024 | Basic loss per common share | Q2 FY2025 | $0.37 – $0.53 | New |
| Jun 13, 2024 | Diluted income per common share | FY2025 | $1.06 – $1.59 | Reaffirmed |
| Jun 13, 2024 | Net loss | Q2 FY2025 | $6.00M – $8.00M | New |
| Jun 13, 2024 | Net income | FY2025 | $18.00M – $27.00M | Reaffirmed |
| Jun 13, 2024 | Net sales | Q2 FY2025 | $152.00M – $160.00M | New |
| Jun 13, 2024 | Net sales | FY2025 | $700.00M – $770.00M | Reaffirmed |
| Apr 11, 2024 | Adjusted EBITDA loss | Q1 FY2025 | $13.00M – $16.00M | New |
| Apr 11, 2024 | Adjusted EBITDA | FY2025 | $46.00M – $60.00M | New |
| Apr 11, 2024 | Basic loss per common share | Q1 FY2025 | $0.84 – $1.03 | New |
| Apr 11, 2024 | Diluted income per common share | FY2025 | $1.06 – $1.59 | New |
| Apr 11, 2024 | Net loss | Q1 FY2025 | $13.00M – $16.00M | New |
| Apr 11, 2024 | Net income | FY2025 | $18.00M – $27.00M | New |
| Apr 11, 2024 | Net sales | Q1 FY2025 | $126.00M – $132.00M | New |
| Apr 11, 2024 | Net sales | FY2025 | $700.00M – $770.00M | New |
| Dec 6, 2023 | Adjusted EBITDA | Q4 FY2024 | $48.00M – $56.00M | New |
| Dec 6, 2023 | Adjusted EBITDA | FY2024 | $54.00M – $62.00M | Narrowed |
| Dec 6, 2023 | Diluted income per common share | Q4 FY2024 | $1.77 – $2.02 | New |
| Dec 6, 2023 | Diluted income per common share | FY2024 | $1.35 – $1.60 | Narrowed |
| Dec 6, 2023 | Net income | Q4 FY2024 | $29.00M – $33.00M | New |
| Dec 6, 2023 | Net income | FY2024 | $22.00M – $26.00M | Narrowed |
| Dec 6, 2023 | Net sales | Q4 FY2024 | $260.00M – $270.00M | New |
| Dec 6, 2023 | Net sales | FY2024 | $710.00M – $720.00M | Lowered |
| Nov 3, 2023 | Adjusted EBITDA | Q3 FY2024 | -$1.50M – $500.00K | New |
| Nov 3, 2023 | Adjusted EBITDA | FY2024 | $51.00M – $63.00M | Lowered |
| Nov 3, 2023 | Diluted loss per common share | Q3 FY2024 | -$0.33 – -$0.20 | New |
| Nov 3, 2023 | Diluted income per common share | FY2024 | $1.21 – $1.75 | Lowered |
| Nov 3, 2023 | Net loss | Q3 FY2024 | -$5.20M – -$3.20M | New |
| Nov 3, 2023 | Net income | FY2024 | $20.00M – $29.00M | Lowered |
| Nov 3, 2023 | Net sales | Q3 FY2024 | $154.00M | New |
| Nov 3, 2023 | Net sales | FY2024 | $710.00M – $730.00M | Narrowed |
| Jun 7, 2023 | Adjusted EBITDA | Q2 FY2024 | $1.00M – $1.50M | New |
| Jun 7, 2023 | Adjusted EBITDA | FY2024 | $55.00M – $66.00M | Reaffirmed |
| Jun 7, 2023 | Diluted loss per common share | Q2 FY2024 | $0.12 – $0.16 | New |
| Jun 7, 2023 | Diluted income per common share | FY2024 | $1.83 – $2.24 | Reaffirmed |
| Jun 7, 2023 | Net loss | Q2 FY2024 | $2.00M – $2.50M | New |
| Jun 7, 2023 | Net income | FY2024 | $30.00M – $36.00M | Reaffirmed |
| Jun 7, 2023 | Net sales | Q2 FY2024 | $149.00M – $151.00M | New |
| Jun 7, 2023 | Net sales | FY2024 | $700.00M – $740.00M | Reaffirmed |
| Mar 28, 2023 | Adjusted EBITDA loss | Q1 FY2024 | $4.00M – $5.00M | New |
| Mar 28, 2023 | Adjusted EBITDA | FY2024 | $55.00M – $66.00M | New |
| Mar 28, 2023 | Diluted loss per common share | Q1 FY2024 | $0.36 – $0.37 | New |
| Mar 28, 2023 | Diluted income per common share | FY2024 | $1.83 – $2.24 | New |
| Mar 28, 2023 | Net loss | Q1 FY2024 | $5.00M – $6.00M | New |
| Mar 28, 2023 | Net income | FY2024 | $30.00M – $36.00M | New |
| Mar 28, 2023 | Net sales | Q1 FY2024 | $133.00M – $136.00M | New |
| Mar 28, 2023 | Net sales | FY2024 | $700.00M – $740.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Lovesac filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Update
- News
- News
- Results
- Results
- Update
- Update
- Update